7.25
+0.20
+(2.84%)
As of 9:30:56 AM GMT+2. Market Open.
Key Executives
Key Executives Information Not Available
Gyre Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Gyre Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 7, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
Gyre Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
BH3.BE PTC Therapeutics Inc
40.40
-1.94%
YDO1.BE Madrigal Pharmaceuticals Inc
277.60
-1.10%
87S.MU Roivant Sciences Ltd
8.88
-0.22%
41X.SG Ardelyx Inc
4.0000
-1.33%
6XC.BE Soleno Therapeutics Inc
61.20
0.00%
1JK.SG Apellis Pharmaceuticals Inc
16.38
-1.40%
9LB.DU Legend Biotech Corp
28.00
-7.28%
ATQP.SG Vericel Corp
35.60
-3.78%
ICY.F Incyte Corporation
51.04
-1.69%
CXF.F Chimerix, Inc.
7.35
-2.39%